Literature DB >> 18061714

Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.

Kensuke Kubota1, Hiroshi Iida, Toshio Fujisawa, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Satoru Saito, Hisashi Ohshiro, Yukio Kakuta, Atushi Nakajima.   

Abstract

BACKGROUND: The rates of spontaneous remission and relapse of autoimmune pancreatitis (AIP) are not known.
OBJECTIVE: To study the clinicopathologic factors predictive of remission and relapse in cases of AIP.
DESIGN: Retrospective study. PATIENTS: Of the 20 patients with AIP, complete response to steroid therapy was recognized in 12 patients, and the remaining 8 patients improved without steroid therapy. Seven patients experienced a relapse.
RESULTS: Patients who were seronegative for immunoglobulin (Ig) G4, had no obstructive jaundice, no diabetes mellitus, no swelling of the duodenal papilla, negative staining of the duodenal papilla for IgG4, and focal pancreatic swelling showed a greater tendency toward spontaneous remission (P < .05). The results of multivariate analysis revealed that negative staining of the duodenal papilla for IgG4 was the only independent predictor of spontaneous remission of AIP (odds ratio [OR] 1.395, P = .0304). Seropositivity for IgG4, diffuse swelling of the pancreas, and the presence of stricture in the lower part of the bile duct were significantly associated with a relapse of AIP (P < .05) according to the results of univariate analysis, whereas the results of multivariate analysis revealed only diffuse pancreatic swelling as an independent predictor of a relapse of AIP (OR 26.197, P = .0331).
CONCLUSIONS: Endoscopic findings are of useful prognostic value, because patients with AIP and with negative staining of the duodenal papilla for IgG4 appeared to have a higher frequency of remission without steroid therapy. Patients with AIP and with diffuse pancreatic swelling were found to be at an increased risk of relapse after the initial steroid administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061714     DOI: 10.1016/j.gie.2007.06.059

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  31 in total

1.  The therapeutic strategy for autoimmune pancreatitis is subject to the endoscopic features of the duodenal papilla.

Authors:  Kensuke Kubota; Atushi Nakajima
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

2.  Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.

Authors:  Kensuke Kubota; Seitaro Watanabe; Takashi Uchiyama; Shingo Kato; Yusuke Sekino; Kaori Suzuki; Hironori Mawatari; Hiroshi Iida; Hiroki Endo; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Satoru Saito; Kazuya Sugimori; Kantaro Hisatomi; Nobuyuki Matsuhashi; Hirotaka Sato; Emiko Tanida; Takashi Sakaguchi; Nobutaka Fujisawa; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-04-15       Impact factor: 7.527

3.  A case of IgG4-related disease with rectal cancer.

Authors:  Norio Itokawa; Masanori Atsukawa; Takayoshi Nishino; Chisa Kondo; Takeshi Fukuda; Yoko Matsushita; Hideko Kidokoro; Tamaki Katakura; Yoshiyuki Narahara; Shu Tanaka; Katsuhisa Nakatsuka; Yoshiharu Oaki; Choitsu Sakamoto
Journal:  Clin J Gastroenterol       Date:  2011-09-22

4.  Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Tetsuhide Ito; Kazuo Inui; Hiroyuki Irie; Takayoshi Nishino; Kenji Notohara; Isao Nishimori; Shigeki Tanaka; Toshimasa Nishiyama; Koichi Suda; Keiko Shiratori; Masao Tanaka; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-03-18       Impact factor: 7.527

5.  Treatment and relapse of autoimmune pancreatitis.

Authors:  Sung-Hoon Moon; Myung-Hwan Kim; Do Hyun Park
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

6.  Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors.

Authors:  Myung-Won You; Jin Hee Kim; Jae Ho Byun; Hyoung Jung Kim; Seung Soo Lee; Myung-Hwan Kim; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2014-02-28       Impact factor: 5.315

7.  Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.

Authors:  Hyun Woo Lee; Sung-Hoon Moon; Myung-Hwan Kim; Dong Hui Cho; Jae Hyuck Jun; Kwangwoo Nam; Tae Jun Song; Do Hyun Park; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee
Journal:  J Gastroenterol       Date:  2018-01-23       Impact factor: 7.527

Review 8.  Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP.

Authors:  Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Tooru Shimosegawa; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

Review 9.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 10.  Type 2 autoimmune pancreatitis: case report of a 9-year-old female and a review of the literature.

Authors:  Zinal Patel; Suril Patel; James Grendell; Tuvia Marciano
Journal:  Clin J Gastroenterol       Date:  2015-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.